Kanjinti (trastuzumab) Injection, 420 mg/Vial, Powder for Reconstitution, Multi-Dose Vial
Kanjinti is a sterile, preservative-free powder for reconstitution containing 420 mg of trastuzumab, a HER2/neu receptor antagonist used in the treatment of HER2-overexpressing cancers. Each multi-dose vial is intended for intravenous administration after reconstitution with the provided diluent. This product is supplied as a single multi-dose vial per pack.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Kanjinti is a sterile, preservative-free powder for reconstitution containing 420 mg of trastuzumab, a HER2/neu receptor antagonist used in the treatment of HER2-overexpressing cancers. Each multi-dose vial is intended for intravenous administration after reconstitution with the provided diluent. This product is supplied as a single multi-dose vial per pack.
1 vendor
